Twin pregnancy with a partial hydatidiform mole and a coexistent live fetus. Diagnostic and therapeutic dilemmas. A case report and the review of literature

被引:8
作者
Gajewska, Malgorzata [1 ]
Zygula, Aleksandra [1 ]
Wielgos, Miroslaw [1 ]
Szewczyk, Grzegorz [2 ]
机构
[1] Med Univ Warsaw, Dept Obstet & Gynecol 1, Warsaw, Poland
[2] Inst Mother & Child Hlth, Ctr Gestat Trophoblast Dis, Warsaw, Poland
关键词
hydatidiform mole; twin pregnancy; ultrasound; histopathological examination; PRENATAL-DIAGNOSIS;
D O I
10.5603/GP.a2020.0109
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: We report the case of a twin pregnancy with a partial hydatidiform mole and a coexistent live fetus diagnosed in a 28-year-old primipara at 15 weeks of gestation and discuss the problems associated with the ultrasound diagnosis, histopathological examination of molar tissue samples and treatment. Material and methods: A systematic research of the literature was conducted in PubMed database and Cochrane Library, including case reports and case series. A new case was also discussed. We collected data regarding the patient's serum human chorionic gonadotropin (hCG) level, initial symptoms, diagnosis and treatment. Results: Most of the cases reported in the literature are those of a multiple pregnancy with complete hydatidiform mole (CHM) and a coexistent live fetus. The coexistence of a twin pregnancy with partial hydatidiform mole (PHM) and a live fetus in two separate amniotic sacs is extremely rare as a partial mole usually causes miscarriage of early pregnancy. Ultrasound is an important diagnostic tool, but the correct diagnosis is made only in 68% of cases. With further histological assessment of molar specimens and biochemical assays, the rates of correct early diagnoses should increase contributing to early therapeutic decisions and fewer adverse events. Conclusions: The diagnosis, management, and monitoring of this condition will remain challenging because of its rarity. Because of that, all cases of a suspected multiple pregnancy with a hydatidiform mole and a coexistent live fetus should be referred to and managed at a tertiary center which specializes in the diagnosis and treatment of gestational trophoblastic disease.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 19 条
[1]  
Braga A, 2017, J ULTRASON, V17, P299, DOI 10.15557/JoU.2017.0044
[2]  
Bristow R E, 1996, Obstet Gynecol Surv, V51, P705, DOI 10.1097/00006254-199612000-00002
[3]   Complete hydatidiform mole and a coexistent viable fetus: Report of two cases and review of the literature [J].
Bruchim, I ;
Kidron, D ;
Amiel, A ;
Altaras, M ;
Fejgin, MD .
GYNECOLOGIC ONCOLOGY, 2000, 77 (01) :197-202
[4]   What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients [J].
Coyle, Christopher ;
Short, Dee ;
Jackson, Lauren ;
Sebire, Neil J. ;
Kaur, Baljeet ;
Harvey, Richard ;
Savage, Philip M. ;
Seckl, Michael J. .
GYNECOLOGIC ONCOLOGY, 2018, 148 (02) :254-257
[5]   Twin Pregnancy with One Fetus and One Complete Mole - A Case Report [J].
Freis, A. ;
Elsaesser, M. ;
Sohn, C. ;
Fluhr, H. .
GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (07) :819-822
[6]   Prenatal Diagnosis of Twin Pregnancies with Complete Hydatidiform Mole and Coexistent Normal Fetus: A Series of 13 Cases [J].
Giorgione, Veronica ;
Cavoretto, Paolo ;
Cormio, Gennaro ;
Valsecchi, Luca ;
Vimercati, Antonella ;
De Gennaro, Alessandra ;
Rabaiotti, Emanuela ;
Candiani, Massimo ;
Mangili, Giorgia .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2017, 82 (04) :404-409
[7]  
Gupta Kanika, 2015, WMJ, V114, P208
[8]  
Imafuku Hitomi, 2018, Kobe J Med Sci, V64, pE1
[9]  
Ingec M, 2006, J Obstet Gynaecol, V26, P379
[10]   Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia [J].
Lybol, C. ;
Sweep, F. C. G. J. ;
Harvey, R. ;
Mitchell, H. ;
Short, D. ;
Thomas, C. M. G. ;
Ottevanger, P. B. ;
Savage, P. M. ;
Massuger, L. F. A. G. ;
Seckl, M. J. .
GYNECOLOGIC ONCOLOGY, 2012, 125 (03) :576-579